New approaches and future prospects for evaluating genetic risk of thrombosisSORIA, José Manuel; FONTCUBERTA, Jordi.Haematologica (Roma). 2005, Vol 90, Num 9, pp 1212-1222, issn 0390-6078, 11 p.Article

Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosisBARBA, Pere; SANTAMARIA, Amparo; TIRADO, Isabel et al.Thrombosis and haemostasis. 2008, Vol 99, Num 2, pp 443-444, issn 0340-6245, 2 p.Article

A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667T mutations, but belonging to an asymptomatic familySORIA, José Manuel; QUINTANA, Rosa; VALLVE, Cristina et al.Haematologica (Roma). 2000, Vol 85, Num 11, pp 1230-1232, issn 0390-6078Article

Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia : An example of a significant decrease of treatment costsMATEO, Jose; BADELL, Isabel; FORNER, Ruth et al.Thrombosis and haemostasis. 2006, Vol 95, Num 2, pp 386-387, issn 0340-6245, 2 p.Article

A genomewide study of body mass index and its genetic correlation with thromboembolic risk: Results from the GAIT projectSOUTO, Juan Carlos; PENA, Georgia; ZIYATDINOV, Andrey et al.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 1036-1043, issn 0340-6245, 8 p.Article

Heritability of Thromboxane A₂ and Prostaglandin E₂ Biosynthetic Machinery in a Spanish PopulationVILA, Luis; MARTINEZ-PEREZ, Angel; SORIA, José-Manuel et al.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 1, pp 128-134, issn 1079-5642, 7 p.Article

Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosisROLDAN, Vanessa; ORDONEZ, Adriana; FONTCUBERTA, Jordi et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 483-486, issn 0340-6245, 4 p.Article

Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular riskCAMACHO, Mercedes; MARTINEZ-PEREZ, Angel; BUIL, Alfonso et al.Atherosclerosis. 2012, Vol 224, Num 1, pp 129-135, issn 0021-9150, 7 p.Article

Haplotypes of the endothelial protein C receptor gene and Behçet's diseaseNAVARRO, Silvia; BONET, Elena; MEDINA, Pilar et al.Thrombosis research. 2012, Vol 129, Num 4, pp 459-464, issn 0049-3848, 6 p.Article

Change in Hemostatic Markers After Recombinant Tissue-Type Plasminogen Activator Is Not Associated With the Chance of RecanalizationMARTI-FABREGAS, Joan; BORRELL, Montserrat; COCHO, Dolores et al.Stroke (1970). 2008, Vol 39, Num 1, pp 234-236, issn 0039-2499, 3 p.Article

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosisCORRAL, Javier; GONZALEZ-CONEJERO, Rocio; ALBERCA, Ignacio et al.Blood. 2006, Vol 108, Num 1, pp 177-183, issn 0006-4971, 7 p.Article

Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implicationsSABATER-LLEAL, Maria; MARTINEZ-MARCHAN, Elisabeth; MARTINEZ-SANCHEZ, Elisabeth et al.Haematologica (Roma). 2003, Vol 88, Num 8, pp 906-913, issn 0390-6078, 8 p.Article

Thromboplastin-thrombomodulin-mediated time and serum folate levels are genetically correlated with the risk of thromboembolic disease: Results from the GAIT projectSOUTO, Juan Carlos; ALMASY, Laura; BORRELL, Montserrat et al.Thrombosis and haemostasis. 2002, Vol 87, Num 1, pp 68-73, issn 0340-6245Article

C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S―independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studiesBUIL, Alfonso; TREGOUËT, David-Alexandre; ALESSI, Marie-Christine et al.Blood. 2010, Vol 115, Num 23, pp 4644-4650, issn 0006-4971, 7 p.Article

Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levelsCALAFELL, Francesc; ALMASY, Laura; MANUEL SORIA, José et al.Human molecular genetics (Print). 2010, Vol 19, Num 3, pp 517-525, issn 0964-6906, 9 p.Article

Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activatorCOCHO, Dolores; BORRELL, Montserrat; MARTINEZ-LAGE, Maria et al.Stroke (1970). 2006, Vol 37, Num 4, pp 996-999, issn 0039-2499, 4 p.Article

Recurrence rate after a first venous thrombosis in patients with familial thrombophiliaVOSSEN, Carla Y; WALKER, Isobel D; FONTCUBERTA, Jordi et al.Arteriosclerosis, thrombosis, and vascular biology. 2005, Vol 25, Num 9, pp 1992-1997, issn 1079-5642, 6 p.Article

A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibilitySORIA, José Manuel; ALMASY, Laura; BLANGERO, John et al.Blood. 2003, Vol 101, Num 1, pp 163-167, issn 0006-4971, 5 p.Article

Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic riskVAYA, Amparo; MIRA, Yolanda; MATEO, Jose et al.Thrombosis and haemostasis. 2003, Vol 89, Num 3, pp 452-457, issn 0340-6245, 6 p.Article

A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic diseaseSORIA, José Manuel; ALMASY, Laura; LATHROP, Mark et al.American journal of human genetics. 2002, Vol 70, Num 3, pp 567-574, issn 0002-9297Article

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficienciesTIRADO, Isabel; MATED, José; SORIA, José Manuel et al.Haematologica (Roma). 2001, Vol 86, Num 11, pp 1200-1208, issn 0390-6078Article

Heritability of plasma concentrations of activated protein C in a Spanish populationSORIA, José M; NAVARRO, Silvia; MEDINA, Pilar et al.Blood coagulation & fibrinolysis. 2009, Vol 20, Num 1, pp 17-21, issn 0957-5235, 5 p.Article

Fibrinolytic inhibitor levels and polymorphisms in Behcet disease and their association with thrombosisRICART, José M; RAMON, Luis A; VAYA, Amparo et al.British journal of haematology. 2008, Vol 141, Num 5, pp 716-719, issn 0007-1048, 4 p.Article

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosisCORRAL, Javier; HERNANDEZ-ESPINOSA, David; MATEO, Jose et al.Blood. 2007, Vol 109, Num 10, pp 4258-4263, issn 0006-4971, 6 p.Article

Patent foramen ovale and prothrombotic markers in young stroke patientsBELVIS, Robert; SANTAMARIA, Amparo; MARTI-FABREGAS, Joan et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 6, pp 537-542, issn 0957-5235, 6 p.Article